Ximi Elga


ENFERMEDAD TROFOBLASTICA GESTACIONAL Epidemiología. Embarazo en los extremos de la edad reproductiva. Multiparidad. ENFERMEDAD. TROFOBLÁSTICA GESTACIONAL MIP K. DENISSE CASTRO SÁNCHEZ. 4 / MALIGNAS GESTACIONAL CORIOCARCINOMA TUMOR. Bajo la denominación de Enfermedad Trofoblástica se agrupan las neoplasias desarrolladas a expensas de la placenta o de las células germinativas de las.

Author: Taushura Gardalkis
Country: Martinique
Language: English (Spanish)
Genre: Art
Published (Last): 21 April 2017
Pages: 411
PDF File Size: 2.59 Mb
ePub File Size: 18.65 Mb
ISBN: 333-3-97682-751-5
Downloads: 14134
Price: Free* [*Free Regsitration Required]
Uploader: Akinor

Marcadores Tumorales

Uruguayan oncology congress; Congreso uruguayo de oncologia; Montevideo Uruguay ; Nov ; Available in abstract form only, full text entered in this record. Use of trofoblasgica markers in clinical practice: Se pueden realizar dos mediciones: Extensive screening for occult malignant disease in idiopathic venous thromboembolism: The usefulness of tumor markers is determined by the sensitivity and specificity of each of them.

Our aim is to review the tumor markers most commonly used in our clinical practice, as well as some agreed recommendations on the indication of their determination in various tumors. Clinical application of tumour markers: Thus, markers with high levels of sensitivity and specificity would allow for the detection of patients with cancer, and for their differentiation from healthy individuals or from patients with benign pathologies.


A 28 years with complete hydatidiform mole A P in enfermddad The presentation with renal and bilateral subcapsular hematoma is a rarity with few reports in the literature.

Eur J Intern Med. East Afr Med J.

Browsing Especialidad en Medicina Materno Fetal by Subject

It aspects discussed diagnostic, prognostic and therapeutic. Medifam revista en la Internet.

Looks like Javascript is disabled on your browser. Related Record Related Record.


National Cancer Institute Consultado Ene Trofoglastica generales de los marcadores tumorales. The Association of Entermedad in Ireland. These molecules, whose serum concentration also depends on the biological variability of the patient, are detectable in different biological fluids. En el tercer grupo, esto es, el de los MT de baja especificidad se incluyen los MT con una sensibilidad dependiente del estadio, pero cuya especificidad es baja, incluso en las fases avanzadas de la enfermedad.

Guidelines for the use of tumour markers. We can say that, in general, due to the lack of high diagnostic sensitivity and specificity, tumor markers are not helpful for an early detection of neoplasms, but they do help to confirm a diagnosis already established by more sensitive methods. Neoplasia oculta en pacientes con trombosis venosa profunda esencial de las extremidades inferiores.


Por ello, el principal dato a tener en cuenta va a ser el cambio cuantitativo de los MT. However, their true clinical value lies in patient monitoring, both for detecting early recurrence and for evaluating the effectiveness of the established treatment.

There was a problem providing the content you requested

The A- P confirms metastases choriocarcinoma support. The choriocarcinoma is an unusual entity being chemosensitive clinical presentation with a renal subcapsular hematomas. R M ab d- pelvic supports multiple hepatic hematomas secundarismo renal subcapsular. Results 1 – 1 of 1. The most common sites of metastasis are lung, liver and CN S. It is a potentially curable enferjedad chemotherapy, even in advanced stages.

Urinary tract ultrasonography and CT pelvis tx- ab d- subcapsular hematomas showed bilateral bulky, up to 6 cm. Urological behavior was watchful waiting. Get permanent URL for this record. Sin embargo, constituyen un reflejo de la actividad de la enfermedad y del crecimiento tumoral.